Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Infection and Immunity

• Publication date

  2016-03-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.01478-15PMID 27001538PMCID PMC4907141
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiological Markers for Interactions Among Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Upper Respiratory Tract Carriage.

  2016cited by this paper
• Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens

  2015cited by this paper
• Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children

  2014cited by this paper
• Dynamic Changes in the Streptococcus pneumoniae Transcriptome during Transition from Biofilm Formation to Invasive Disease upon Influenza A Virus Infection

  2014influential reference
• Viral and Bacterial Interactions in the Upper Respiratory Tract

  2013cited by this paper
• Interkingdom Signaling Induces Streptococcus pneumoniae Biofilm Dispersion and Transition from Asymptomatic Colonization to Disease

  2013influential reference
• LT-IIb(T13I), a Non-Toxic Type II Heat-Labile Enterotoxin, Augments the Capacity of a Ricin Toxin Subunit Vaccine to Evoke Neutralizing Antibodies and Protective Immunity

  2013cited by this paper
• The potential of human nasal colonization with Streptococcus pneumoniae as a universal pneumococcal vaccine.

  2013cited by this paper
• Nasopharyngeal Bacterial Interactions in Children

  2012cited by this paper
• High Levels of Genetic Recombination during Nasopharyngeal Carriage and Biofilm Formation in Streptococcus pneumoniae

  2012cited by this paper
• Associations between Pathogens in the Upper Respiratory Tract of Young Children: Interplay between Viruses and Bacteria

  2012cited by this paper
• Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship?

  2012cited by this paper
• Estimating Rates of Carriage Acquisition and Clearance and Competitive Ability for Pneumococcal Serotypes in Kenya With a Markov Transition Model

  2012cited by this paper
• Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice.

  2011cited by this paper
• Swine influenza (H1N1) pneumonia in hospitalized adults: chest film findings.

  2011cited by this paper
• Contribution of vaccines to our understanding of pneumococcal disease

  2011cited by this paper
• Role of Dihydrolipoamide Dehydrogenase in Regulation of Raffinose Transport in Streptococcus pneumoniae

  2011cited by this paper
• Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose.

  2011cited by this paper
• Influenza virus induces bacterial and nonbacterial otitis media.

  2011cited by this paper
• Invasive bacterial infections in relation to influenza outbreaks, 2006-2010.

  2011cited by this paper
• Viral-Bacterial Interactions and Risk of Acute Otitis Media Complicating Upper Respiratory Tract Infection

  2011cited by this paper
• Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study.

  2010cited by this paper
• Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection - United States, April-August 2009.

  2009cited by this paper
• Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection.

  2009cited by this paper
• Analyzing real-time PCR data by the comparative CT method

  2008cited by this paper
• Pneumococcal vaccination of elderly adults: new paradigms for protection.

  2008cited by this paper
• Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization--in HIV-Infected and HIV-uninfected children.

  2007cited by this paper
• Contributions of Pneumolysin, Pneumococcal Surface Protein A (PspA), and PspC to Pathogenicity of Streptococcus pneumoniae D39 in a Mouse Model

  2007cited by this paper
• Pneumolysin, PspA, and PspC Contribute to Pneumococcal Evasion of Early Innate Immune Responses during Bacteremia in Mice

  2007cited by this paper
• PspA and PspC Minimize Immune Adherence and Transfer of Pneumococci from Erythrocytes to Macrophages through Their Effects on Complement Activation

  2007cited by this paper
• Vaccines in the era of genomics: the pneumococcal challenge.

  2007cited by this paper
• Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries.

  2006cited by this paper
• Streptococcus pneumoniae Protein Vaccine Candidates: Properties, Activities and Animal Studies

  2006cited by this paper
• Pneumococcal vaccination in developing countries.

  2006cited by this paper
• Pneumococcal vaccination in developing countries.

  2006cited by this paper
• Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.

  2006cited by this paper
• Development of a Vaccine against Invasive Pneumococcal Disease Based on Combinations of Virulence Proteins of Streptococcus pneumoniae

  2006cited by this paper
• Insights into the Interaction between Influenza Virus and Pneumococcus

  2006cited by this paper
• Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults.

  2006cited by this paper
• Mucosal Adjuvant Properties of Mutant LT-IIa and LT-IIb Enterotoxins That Exhibit Altered Ganglioside-Binding Activities

  2005cited by this paper
• Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.

  2005cited by this paper
• A role for Streptococcus pneumoniae in virus-associated pneumonia

  2004cited by this paper
• Effects of PspA and Antibodies to PspA on Activation and Deposition of Complement on the Pneumococcal Surface

  2004cited by this paper
• Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children.

  2004cited by this paper
• Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children.

  2004cited by this paper
• Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.

  2003cited by this paper
• Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.

  2003cited by this paper
• Both Family 1 and Family 2 PspA Proteins Can Inhibit Complement Deposition and Confer Virulence to a Capsular Serotype 3 Strain of Streptococcus pneumoniae

  2003cited by this paper
• Importance of Respiratory Viruses in Acute Otitis Media

  2003cited by this paper
• Characterization of Binding of Human Lactoferrin to Pneumococcal Surface Protein A

  2001cited by this paper
• Additive Attenuation of Virulence ofStreptococcus pneumoniae by Mutation of the Genes Encoding Pneumolysin and Other Putative Pneumococcal Virulence Proteins

  2000cited by this paper
• Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.

  2000cited by this paper
• Comparative Analysis of the Mucosal Adjuvanticity of the Type II Heat-Labile Enterotoxins LT-IIa and LT-IIb

  2000cited by this paper
• The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.

  2000cited by this paper
• Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA Is Highly Protective against Nasopharyngeal Carriage of Streptococcus pneumoniae

  2000influential reference
• Pneumococcal Surface Protein A Inhibits Complement Activation by Streptococcus pneumoniae

  1999cited by this paper
• Pneumococcal Diversity: Considerations for New Vaccine Strategies with Emphasis on Pneumococcal Surface Protein A (PspA)

  1998cited by this paper
• Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae.

  1997cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA)

  1987cited by this paper
• Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells

  1983influential reference
• Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody.

  1975cited by this paper
• Optochin in the Identification of Str. pneumoniae

  1955cited by this paper
• STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES

  1944influential reference

• Immunization with recombinant Streptococcus pneumoniae PgdA protects mice against lung invasion

  2024cites this paper
• Streptococcus pneumoniae binds to host GAPDH on dying lung epithelial cells worsening secondary infection following influenza

  2021cites this paper
• A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age

  2021cites this paper
• Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae

  2021cites this paper
• Host-informed therapies for the treatment of pneumococcal pneumonia.

  2021cites this paper
• The long search for a serotype independent pneumococcal vaccine

  2020cites this paper
• The serine protease HtrA plays a key role in heat-induced dispersal of pneumococcal biofilms

  2020cites this paper
• A Murine Model for the Transition of Streptococcus pneumoniae from Asymptomatic Colonizer to Systemic Pathogen

  2020cites this paper
• Protective responses of an engineered PspA recombinant antigen against Streptococcus pneumoniae

  2019cites this paper
• Effect of a pneumococcal whole cell vaccine on influenza A-induced pneumococcal otitis media in infant mice.

  2019cites this paper
• Biofilm formation and biofilm dispersal with Streptococcus pneumoniae

  2019cites this paper
• Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary Streptococcus pneumoniae Challenge during Influenza A Infection

  2019cites this paper
• Panel 8: Vaccines and immunology.

  2019cites this paper
• Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.

  2018cites this paper
• Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies

  2017cites this paper
• Longitudinal Analysis of Genetic and Environmental Data from an Agricultural Cohort Living in Yakima Valley Reveals an Agricultural Exposome

  2017cites this paper
• Innovative Approaches to Improve Anti-Infective Vaccine Efficacy.

  2017cites this paper
• Molecular characterization of Streptococcus pneumoniae, particularly serotype19A/ST320, which emerged in Krasnoyarsk, Russia

  2017cites this paper
• Human Oral Buccal Microbiomes Are Associated with Farmworker Status and Azinphos-Methyl Agricultural Pesticide Exposure

  2016cites this paper